Dr. Nitesh Rohatgi 
Senior Director
26 Years of ExperienceMedical Oncologist
MBBS, DNB, MNAMS, CCT, Fellowship, MRCP, FRCP
Reg. No.:5989, Delhi Medical Council
Fortis Memorial Research Institute (FMRI), Gurgaon
Max Institute of Cancer Care, Lajpat Nagar, New Delhi
Fortis Cancer Institute, Defence Colony, New Delhi
English, Hindi
Consultation Fee ₹ 1800
Book an AppointmentAbout Dr. Nitesh Rohatgi
- Dr. Nitesh Rohatgi is a renowned Medical Oncologist in India.
- He has 26 years of rich experience in treating different types of cancer.
- Dr. Rohatgi's specialty interests include Breast, Lung, Gynecological, Gastrointestinal, and Hepatobiliary Cancers, Brain Tumors, Head and Neck Cancers, and Kidney, Bladder, and Prostate Cancers.
- After completing his MBBS in 1998, he completed a DNB in Medical Oncology from the University of Delhi in 2000.
- He received MNAMS from the National Academy of Medical Sciences, Dundee, UK, Fellowship of the Royal Schools of Music (FRSM), London, and (MRCP), Royal Colleges of Physicians, London.
- He is a fellow of both the Royal College of Physicians (UK Edinburgh) and the Royal Society of Medicine.
- With numerous publications to his credit, Dr. Rohatgi brings a wealth of research experience to his practice.
- His medical training encompasses medical oncology, palliative medicine, and adolescent and young adult cancers acquired in the United Kingdom
Book Your Appointment With Dr. Nitesh Rohatgi
Get a Treatment Plan Within 1 Hour
Education
- MBBS, University of Delhi, 1998
- DNB, (Medical Oncology), University of Delhi, 2000
- MNAMS, National Academy of Medical Sciences, Dundee, UK
- CCT Leeds, UK
- Fellowship of the Royal Schools of Music (FRSM), London
- (MRCP Royal Colleges of Physicians, London
- Fellow of the Royal College of Physicians (FRCP), Edin, UK
Past Experience
- Consultant Medical Oncology at St. James's Institute of Oncology, 2010
- Consultant medical oncology, Leeds Teaching Hospitals NHS Trust
Paper Published
- Liquid Biopsy for Detection of Pancreaticobiliary Cancers by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and Their Clusters
- Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India
- Liquid Biopsy for Detection of Pancreaticobiliary Cancers in Suspected Patients by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and their Clusters
- Liquid and tissue profiling of somatic mutational landscape of non-small cell lung cancer from an Indian cohort.
- Comprehensive molecular profiling from liquid and tissue for analysing the somatic mutational landscape in an Indian breast cancer cohort.
- Does the landscape of comprehensive genomic profiling in patients with advanced stage lung cancer in India differ from data from the western countries.
- Pan-cancer analysis of tumor mutation burden and other key ICI biomarkers in the Indian cohort.
- Importance of clinical decision making in precision oncology: Discordance in recommendation between next generation sequencing test vendor and molecular tumour board in India.
- Liquid and tissue profiling of targetable co-mutations with KRAS in non-small cell lung cancer.
- P-209 Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers
- Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells
- 267P Genomic landscape of non-small cell lung cancer (NSCLC) in India using circulating tumor DNA (ctDNA) in clinical practice
- Indian Perspective On 17th St. Gallen: Customizing Local and Systemic Therapies for Indian Women with Breast Cancer
- Knowledge, attitudes, and perception of 398 cancer patients toward participation in clinical trials: A single-center study from New Delhi, India
- Treatment of advanced non-small-cell lung cancer: First line, maintenance, and second line– Indian consensus statement update(Under the aegis of Lung Cancer Consortium Asia, Indian Cooperative Oncology Network, Indian Society of Medical and Pediatric Oncology, Molecular Oncology Society, and Association of Physicians of India)
- Weekly chemotherapy instead of best supportive care alone must be considered for patients of small cell lung cancer with poor performance status.
- Clinical applicability of comprehensive genomic profiling (CGP) and assessment of tumor mutation burden (TMB): An Indian experience.
- Practical consensus recommendations on fertility preservation in patients with breast cancer
- Practical consensus recommendations on fertility preservation in patients with breast cancer
- A preliminary study on congenital toxoplasmosis in India
Field of Expertise
- Adrenal Cancer Treatment
- Benign and Cancerous Tumor Excision
- Bile Duct Cancer Treatment
- Brain Tumor Surgery
- Breast Biopsy
- CAR T-Cell Therapy
Best Oncology Doctors in India
Dr. Ashok Kumar Vaid
Chairman
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert
Dr. Satya Pal Kataria
Vice Chairman
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert
Dr. Chandragouda Dodagoudar
Director
Medical Oncologist
BLK-Max Super Speciality Hospital, New Delhi
Book an Appointment Talk To Expert
Dr. Kunjahari Medhi
Senior Director
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert